Joshua Cooper Ramo
Known title: DirectorCIK: 0001519406
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Starbucks Faces Growing Problem Despite Returning Customers. Starbucks is dealing with a growing problem even as customers return, according to recent reports. The stock has risen 15% year‑to‑date, prompting questions about further upside. Jim Cramer noted that Starbucks can rise on its own, highlighting the company's resilience.
Transaction History
| FDX | ▲ Buy | Option Exercise | 5,042 | $695K | 9/24/2026 | View on chart |
| FDX | ▼ Sell | Tax Withholding | 2,436 | $695K | 9/24/2026 | View on chart |
| FDX | ▲ Buy | Grant | 823 | $0 | 9/29/2025 | View on chart |
| FDX | ▲ Buy | Grant | 591 | $140K | 9/29/2025 | View on chart |
| FDX | ▼ Sell | Open Market | 3,610 | $838K | 7/23/2025 | View on chart |
| FDX | ▲ Buy | Option Exercise | 3,610 | $513K | 7/23/2025 | View on chart |
| FDX | ▲ Buy | Grant | 755 | $0 | 9/23/2024 | View on chart |
| FDX | ▲ Buy | Grant | 542 | $140K | 9/23/2024 | View on chart |
| FDX | ▲ Buy | Grant | 745 | $0 | 9/22/2023 | View on chart |
| FDX | ▲ Buy | Grant | 534 | $140K | 9/22/2023 | View on chart |
| FDX | ▲ Buy | Grant | 954 | $140K | 9/26/2022 | View on chart |
| SBUX | ▲ Buy | Grant | 3,546 | $0 | 3/16/2022 | View on chart |
| FDX | ▲ Buy | Grant | 615 | $140K | 9/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking
FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking. FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.